計畫


第 1 到 12 筆結果，共 12 筆。

啟始時間標題P-Investigator經費來源
2023Exploring the Role of Tertiary Lymphoid Structures in Mechanistic Research and New Drug Development for Immunotherapy of Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council
2022Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic ImplicationsDA-LIANG OUNational Science and Technology Council
2021Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic ImplicationsDA-LIANG OUNational Science and Technology Council
2020Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic ImplicationsDA-LIANG OUNational Science and Technology Council
2019Modulation of the Cellular Energy Metabolism to Enhance the Efficacy of Immunotherapy for Hepatocellular Carcinoma: Mechanistic ExplorationDA-LIANG OUNational Science and Technology Council
2018Modulation of the Cellular Energy Metabolism to Enhance the Efficacy of Immunotherapy for Hepatocellular Carcinoma: Mechanistic ExplorationDA-LIANG OUNational Science and Technology Council
2017Modulation of the Cellular Energy Metabolism to Enhance the Efficacy of Immunotherapy for Hepatocellular Carcinoma: Mechanistic ExplorationDA-LIANG OUNational Science and Technology Council
2016Exploring Synergistic Effect between Cyclin-Dependent Kinase (Cdk) Inhibitors and Sorafenib for the Treatment of Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council
2015DKK1 as a Therapeutic Target of Molecular Targeted Therapy for Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council
2014DKK1 as a Therapeutic Target of Molecular Targeted Therapy for Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council
2013DKK1 as a Therapeutic Target of Molecular Targeted Therapy for Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council
2011Exploring the Roles of miR-10b* and miR885-5p as Predictive Biomarkers and Therapeutic Targets of Sorafenib for the Treatment of Hepatocellular CarcinomaDA-LIANG OUNational Science and Technology Council